NO148522B - PROCEDURE FOR THE PREPARATION OF NEW ALFA-ACYLOXY-ACETAMIDES - Google Patents

PROCEDURE FOR THE PREPARATION OF NEW ALFA-ACYLOXY-ACETAMIDES

Info

Publication number
NO148522B
NO148522B NO794314A NO794314A NO148522B NO 148522 B NO148522 B NO 148522B NO 794314 A NO794314 A NO 794314A NO 794314 A NO794314 A NO 794314A NO 148522 B NO148522 B NO 148522B
Authority
NO
Norway
Prior art keywords
general formula
amino
tert
acid
phenyl
Prior art date
Application number
NO794314A
Other languages
Norwegian (no)
Other versions
NO148522C (en
NO794314L (en
Inventor
Jarkko Ruohonen
Kauko Nieminen
Johannes Keck
Gerd Krueger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI790067A external-priority patent/FI59396C/en
Priority claimed from DE19792942723 external-priority patent/DE2942723A1/en
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO794314L publication Critical patent/NO794314L/en
Publication of NO148522B publication Critical patent/NO148522B/en
Publication of NO148522C publication Critical patent/NO148522C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)

Description

Denne oppfinnelse angår en fremgangsmåte for fremstilling This invention relates to a method for manufacturing

av nye a-acyloksy-acetamider med den generelle formel of new α-acyloxy-acetamides of the general formula

som kan anvendes som mellomprodukter for fremstilling av fenyletanolaminer med den generelle formel which can be used as intermediates for the production of phenylethanolamines with the general formula

som er i besittelse av verdifulle, farmakologiske egenskaper, which possess valuable pharmacological properties,

særlig bronkolytiske virkninger. particularly broncholytic effects.

I de ovenstående generelle formler I og II betyr In the above general formulas I and II mean

R^ et klor- eller bromatom, R^ a chlorine or bromine atom,

1*2 en trifluormetylgruppe, et fluor- eller kloratom, 1*2 a trifluoromethyl group, a fluorine or chlorine atom,

R-. en forgrenet alkylrest eller en cykloalkylgruppe med hver R-. a branched alkyl residue or a cycloalkyl group with each

3 til 5 karbonatomer, og 3 to 5 carbon atoms, and

R^ gruppen COR hvor R er en alkylrest med 1-4 karbonatomer R^ the group COR where R is an alkyl residue with 1-4 carbon atoms

eller en fenylrest. or a phenyl residue.

Blant de innledningsvis angitte betydninger ved defini- Among the initially stated meanings when defining

sjonen av restene R^ og , kommer for R^ særlig i betraktning en isopropyl-, isobutyl-, tert.butyl-, isopentyl-, neopentyl-, tert.pentyl-, cyklopropyl-, cyklobutyl- eller cyklopentyl- tion of the radicals R^ and , for R^ comes in particular an isopropyl-, isobutyl-, tert.butyl-, isopentyl-, neopentyl-, tert.pentyl-, cyclopropyl-, cyclobutyl- or cyclopentyl-

gruppe, og for R^ en acylrest av en alifatisk karboksylsyre så som eddiksyre, propionsyre, trimetyleddiksyre eller vale- group, and for R^ an acyl residue of an aliphatic carboxylic acid such as acetic acid, propionic acid, trimethylacetic acid or vale-

riansyre, eller benzoesyre. rianic acid, or benzoic acid.

I henhold til oppfinnelsen fremstilles de nye a-acyloksy-acetamider med den generelle formel I ved omsetning av et 4-amino-benzaldehyd med den generelle formel According to the invention, the new α-acyloxy-acetamides with the general formula I are prepared by reacting a 4-amino-benzaldehyde with the general formula

hvor R, og R^ er som innledningsvis angitt, med et isonitril med den generelle formel hvor R^ er som innledningsvis angitt, og med en karboksylsyre med deri generelle formel where R, and R^ are as indicated initially, with an isonitrile of the general formula where R^ is as indicated initially, and with a carboxylic acid of general formula therein

hvor R^ er som innledningsvis angitt. where R^ is as indicated at the outset.

For fremstilling av et fenyletanolamin med den generelle formel II reduseres et således erholdt a-acyloksy-acetamid med den generelle formel I, som også kan videreomsettes som råprodukt, med et hydrid, f.eks. med et metallhydrid eller et komplekst metallhydrid så som boran/tetrahydrofuran eller litiumaluminiumhydrid. For the production of a phenylethanolamine of the general formula II, an α-acyloxy-acetamide of the general formula I obtained in this way, which can also be further converted as a crude product, is reduced with a hydride, e.g. with a metal hydride or a complex metal hydride such as borane/tetrahydrofuran or lithium aluminum hydride.

Omsetningen av et 4-amino-benzaldehyd med den generelle formel III med et isonitril med den generelle formel IV og med en karboksylsyre med den generelle formel V foretas hensiktsmessig i et egnet oppløsningsmiddel så som metylenklorid, kloroform, benzen, eter, tetrahydrofuran eller dioksan, ved lavere temperaturer, f.eks. ved temperaturer mellom -20 og 75°C, hensiktsmessig ved romtemperatur. Omsetningen utføres fortrinnsvis slik at under omrøring og ved romtemperatur tilsettes dråpevis enten samtidig fra hver sin dråpetrakt, en forbindelse med den generelle formel IV og en karboksylsyre med den generelle formel V til en oppløsning av et aldehyd med den generelle formel III, eller en karboksylsyre med den generelle formel V til en oppløsning av et isonitril med den generelle formel IV og et aldehyd med den generelle formel III, i løpet av flere timer, f.eks. 5-10 timer, og derefter omrøres i 10 til 165 timer. The reaction of a 4-amino-benzaldehyde of the general formula III with an isonitrile of the general formula IV and with a carboxylic acid of the general formula V is suitably carried out in a suitable solvent such as methylene chloride, chloroform, benzene, ether, tetrahydrofuran or dioxane, at lower temperatures, e.g. at temperatures between -20 and 75°C, suitably at room temperature. The reaction is preferably carried out so that, with stirring and at room temperature, a compound of the general formula IV and a carboxylic acid of the general formula V are added dropwise, either simultaneously from each drop funnel, to a solution of an aldehyde of the general formula III, or a carboxylic acid of the general formula V to a solution of an isonitrile of the general formula IV and an aldehyde of the general formula III, in the course of several hours, e.g. 5-10 hours, and then stirred for 10 to 165 hours.

Reduksjonen av et erholdt cc-acyloksy-acetamid med den generelle formel I med et hydrid foretas fortrinnsvis i et egnet oppløsningsmiddel så som eter, tetrahydrofuran eller dioksan ved lavere eller svakt forhøyede temperaturer, f.eks. ved temperaturer mellom 0 og 100°C, hensiktsmessig ved reaksjons-blandingens koketemperatur. Særlig fordelaktig utføres imidlertid denne reduksjon med boran/tetrahydrofuran ved koke-temperaturen for det som oppløsningsmiddel anvendte tetrahydrofuran. The reduction of an obtained cc-acyloxy-acetamide of the general formula I with a hydride is preferably carried out in a suitable solvent such as ether, tetrahydrofuran or dioxane at lower or slightly elevated temperatures, e.g. at temperatures between 0 and 100°C, suitably at the boiling temperature of the reaction mixture. Particularly advantageously, however, this reduction is carried out with borane/tetrahydrofuran at the boiling temperature of the tetrahydrofuran used as solvent.

Isoleringen av det ønskede sluttprodukt med den generelle formel II foretas hensiktsmessig over vandige baser, f.eks. over vann/ammoniakk, hvorved en eventuelt ennu tilstedeværende a-acyloksygruppe avspaltes. The isolation of the desired end product with the general formula II is conveniently carried out over aqueous bases, e.g. over water/ammonia, whereby a possibly still present α-acyloxy group is split off.

Et således erholdt fenyletanolamin med den generelle formel II kan eventuelt derefter overføres med en uorganisk eller organisk syre til sitt fysiologisk forlikelige syre-addisjonssalt med vedkommende syre. Som syrer kan f.eks. anvendes saltsyre, bromhydrogensyre, svovelsyre, fosforsyre, melkesyre, vinsyre, sitronsyre, fumarsyre eller maleinsyre. A phenylethanolamine of the general formula II thus obtained can optionally then be transferred with an inorganic or organic acid to its physiologically compatible acid addition salt with the acid in question. As acids, e.g. hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, lactic acid, tartaric acid, citric acid, fumaric acid or maleic acid are used.

De som utgangsstoffer anvendte forbindelser med de generelle formler IV og V er kjent fra litteraturen. The compounds of the general formulas IV and V used as starting materials are known from the literature.

Et som utgangsstoff anvendt aldehyd med den generelle formel III får man f.eks. ved reduksjon av et tilsvarende 4-amino-benzoesyrehalogenid eller -ester og påfølgende oksydasjon av den eventuelt erholdte benzylalkohol med brunsten. An aldehyde with the general formula III used as a starting material gives, for example, by reduction of a corresponding 4-amino-benzoic acid halide or ester and subsequent oxidation of the possibly obtained benzyl alcohol with the tan.

Fra litteraturen er det tidligere kjent en fremgangsmåte for fremstilling av fenyletanolaminene med den generelle formel II, som kjennetegnes ved at et glykolsyreamid med den generelle formel A method for the preparation of the phenylethanolamines of the general formula II is previously known from the literature, which is characterized by the fact that a glycolic acid amide of the general formula

hvor R^, R£ og R^ er som ovenfor angitt, reduseres med et komplekst metallhydrid. where R^, R£ and R^ are as indicated above, is reduced with a complex metal hydride.

Denne fremgangsmåte oppviser imidlertid den ulempe at However, this method has the disadvantage that

de som utgangsstoffer nødvendige glykolsyreamider er vanskelige å fremstille. the glycolic acid amides required as starting materials are difficult to produce.

De gode utbytter som oppnås ved fremgangsmåten ifølge oppfinnelsen, kunne ikke forutsees av en fagmann, eftersom det er kjent fra litteraturen (se J. Amer. Chem. Soc. 67, 1499-1500 (1945)), at Passerini-reaksjonen ikke kan gjennom-føres med sterisk hindrede og med a,(3-umettede karbonylforbindelser. Her forklares den manglende reaktivitet hos a,3-umettede karbonylforbindelser, f.eks. av krotonaldehyd, The good yields obtained by the process according to the invention could not be predicted by a person skilled in the art, since it is known from the literature (see J. Amer. Chem. Soc. 67, 1499-1500 (1945)) that the Passerini reaction cannot go through - is carried out with sterically hindered and with α,(3-unsaturated carbonyl compounds. This explains the lack of reactivity with α,3-unsaturated carbonyl compounds, e.g. of crotonaldehyde,

i forhold til Passerini-reaksjonen ved nøytralisering av det elektroniske sentrum av karbonylfunksjonen på grunn av de mesomere grensestrukturer in relation to the Passerini reaction by neutralization of the electronic center of the carbonyl function due to the mesomeric boundary structures

altså på grunn av den elektronavgivende virkning hos en nabo-gruppe. that is, due to the electron-donating effect of a neighboring group.

Videre er det kjent at aminogruppen i o- eller p-stilling i en fenylkjerne har en sterk elektronavgivende virkning. Furthermore, it is known that the amino group in the o- or p-position in a phenyl nucleus has a strong electron-donating effect.

En fagmann måtte således vente at det elektroniske sentrum i karbonyifunksjonen i et 4-amino-benzaldehyd med den generelle formel III, på grunn av den mesomere grensestruktur med den generelle formel A person skilled in the art would thus have to expect that the electronic center in the carbonyl function in a 4-amino-benzaldehyde of the general formula III, due to the mesomeric boundary structure of the general formula

deaktiveres og at Passerini-reaksjonen således ikke er til-gjengelig. Overraskende er det funnet at dette ikke er tilfelle. is deactivated and that the Passerini reaction is thus not available. Surprisingly, it has been found that this is not the case.

De følgende eksempler skal illustrere oppfinnelsen ytterligere. The following examples shall further illustrate the invention.

Eksempel 1 Example 1

g- acetoksy- g-( 4- amino- 3, 5- diklor- fenyl)- N- tert. butyl- acetamid g- acetoxy- g-(4- amino- 3, 5- dichloro- phenyl)- N- tert. butyl acetamide

Til en oppløsning av 3,8 g (0,02 mol) 4-amino-3,5-diklor-benzaldehyd i 50 ml absolutt metylenklorid setter man dråpevis under omrøring ved romtemperatur 3,32 g (0,04 mol) tert.butyl-isonitril og 4,8 g (0,08 mol) iseddik fra to adskilte dråpe-trakter med samme hastighet i løpet av 8 timer. Derefter inndampes den erholdte oppløsning til halvt volum og avkjøles. Det herved utfelte, uomsatte 4-amino-3,5-diklorbenzaldehyd avsuges, og filtratet inndampes påny til halvt volum. Til den erholdte blanding setter man det samme volum diisopropyleter, hvorved det ønskede produkt utkrystalliserer, avsuges og vaskes med diisopropyleter. To a solution of 3.8 g (0.02 mol) 4-amino-3,5-dichloro-benzaldehyde in 50 ml absolute methylene chloride, 3.32 g (0.04 mol) tert-butyl is added dropwise while stirring at room temperature -isonitrile and 4.8 g (0.08 mol) glacial acetic acid from two separate dropping funnels at the same rate during 8 hours. The resulting solution is then evaporated to half volume and cooled. The thus precipitated, unreacted 4-amino-3,5-dichlorobenzaldehyde is suctioned off, and the filtrate is evaporated again to half the volume. The same volume of diisopropyl ether is added to the resulting mixture, whereby the desired product crystallizes out, is filtered off and washed with diisopropyl ether.

Smeltepunktæ 175-176°C. Melting point 175-176°C.

Eksempel 2 Example 2

g- acetoksy- g-( 4- amino- 3, 5- diklor- fenyl)- N- tert. butyl- acetamid g- acetoxy- g-(4- amino- 3, 5- dichloro- phenyl)- N- tert. butyl acetamide

Til en oppløsning av 30 g (0,16 mol) 4-amino-3,5-diklor-benzaldehyd i 280 ml metylenklorid settes 45 ml tert.butyl-isocyanid og derefter dråpevis under omrøring og ved romtemperatur ca. 40 ml iseddik i løpet av 16 timer. Derefter omrører man i ytterligere 4 timer og inndamper i vakuum inntil de første krystaller faller ut. Efter avkjøling til 0°C avsuges det utfelte, uomsatte 4-amino-3,5-diklorbenzaldehyd. Dette kan omsettes direkte påny. Filtratet tilsettes n-heksan, hvorved det ønskede produkt utfelles. Bunnfallet avsuges, vaskes med n-heksan og tørres. To a solution of 30 g (0.16 mol) 4-amino-3,5-dichloro-benzaldehyde in 280 ml of methylene chloride is added 45 ml of tert-butyl isocyanide and then dropwise with stirring and at room temperature approx. 40 ml of glacial acetic acid within 16 hours. The mixture is then stirred for a further 4 hours and evaporated in vacuo until the first crystals fall out. After cooling to 0°C, the precipitated, unreacted 4-amino-3,5-dichlorobenzaldehyde is suctioned off. This can be traded directly again. n-hexane is added to the filtrate, whereby the desired product is precipitated. The precipitate is filtered off, washed with n-hexane and dried.

Smeltepunkt: 175-176°C. Melting point: 175-176°C.

Eksempel 3 Example 3

1- ( 4- amino- 3, 5- diklor- fenyl)- 2- tert. butylamino- etanol 1-( 4- amino- 3, 5- dichloro- phenyl)- 2- tert. butylamino-ethanol

Til en oppløsning av 4,01 g g<->acetoksy-a-(4-amino-3,5-diklorfenyl)-N-tert.butyl-acetamid i 50 ml absolutt tetrahydrofuran settes 100 ml av en 1 molar oppløsning av boran i tetrahydrofuran. Efter 2 timers omrøring under tilbakeløpskjøling foretas inndampning, 100 ml vann tilsettes, og blandingen sur-gjøres med saltsyre til pH 2. Den vandige fase vaskes med etyl-acetat, gjøres derefter alkalisk med ammoniakk og ekstraheres med metylenklorid. Efter inndampning av den organiske fase får man hydrokloridet fra isopropanol ved tilsetning av eterisk saltsyre. 100 ml of a 1 molar solution of borane in tetrahydrofuran. After stirring for 2 hours under reflux, evaporation is carried out, 100 ml of water is added, and the mixture is acidified with hydrochloric acid to pH 2. The aqueous phase is washed with ethyl acetate, then made alkaline with ammonia and extracted with methylene chloride. After evaporation of the organic phase, the hydrochloride is obtained from isopropanol by adding ethereal hydrochloric acid.

Smeltepunkt for hydrokloridet: 174-175°C. Melting point for the hydrochloride: 174-175°C.

Eksempel 4 Example 4

g- acetoksy- g - ( 4- amino- 3- klor- 5- trifluormety1- fenyl)- eddiksyre-tert. butylamid g-acetoxy-g-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-acetic acid-tert. butylamide

Til en oppløsning av 4,47 g (20 mmol) 4-amino-3-klor~5-trifluormety1-benzaldehyd i 50 ml metylenklorid settes dråpevis ved romtemperatur under omrøring 3,32 g (40 mmol) tert.butyl-isonitril og 4,8 g (80 mmol) iseddik samtidig i løpet av 5 timer, og derefter omrøres blandingen i 65 timer ved romtemperatur. Efter fjernelse av oppløsningsmidlet i vakuum, oppløses residuet i eter, vaskes med vann og derefter med en mettet natriumbikarbonatoppløsning, tørres over magnesiumsulfat og inndampes til tørrhet i vakuum. Residuet kromatograferer man over en silikagelkoionne med metylenklorid som eluerings-middel. Fraksjonene som inneholder den ønskede forbindelse, samles, inndampes, og residuet krystalliseres fra eter. Smeltepunkt: 155-156°C. 3.32 g (40 mmol) of tert-butyl isonitrile and 4 .8 g (80 mmol) of glacial acetic acid at the same time during 5 hours, and then the mixture is stirred for 65 hours at room temperature. After removal of the solvent in vacuo, the residue is dissolved in ether, washed with water and then with a saturated sodium bicarbonate solution, dried over magnesium sulfate and evaporated to dryness in vacuo. The residue is chromatographed over a silica gel column with methylene chloride as eluent. The fractions containing the desired compound are collected, evaporated, and the residue crystallized from ether. Melting point: 155-156°C.

Eksempel 5 Example 5

1-( 4- amino- 3- klor- 5- trifluormetyl- fenyl)- 2- tert. butylamino-etanol- hydroklorid 1-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2- tert. butylaminoethanol hydrochloride

2 g (5,4 mmol) g-acetoksy-g- (4-amino-3-klor-5-trifluor-metylfenyl)-eddiksyre-tert.butylamid oppløses i 15 ml absolutt tetrahydrofuran og settes i én porsjon under nitrogen til 27 ml av en 1 molar oppløsning av boran i tetrahydrofuran. Efter 4 timers kokning under tilbakeløpskjøling tilsetter man ytterligere 15 ml 1 molar boranoppløsning og oppvarmer videre i 2 timer under tilbakeløpskjøling. Derefter ødelegges over-skuddet av boran med aceton, borkomplekset spaltes med vann, og derefter avdampes oppløsningsmidlet i vakuum. Den vandige destillasjonsrest surgjøres med 2N saltsyre til pH 1, gjøres igjen alkalisk med ammoniakk og ekstraheres med eter. Eterekstrakten ekstraheres med 0,5N saltsyre, den sure oppløsning vaskes med eter, gjøres alkalisk med ammoniakk og ekstraheres påny med eter. Eterekstrakten vaskes med vann, tørres med magnesiumsulfat og inndampes i vakuum. Det oljeaktige inn-dampningsresiduum oppløses i eter og surgjøres med eterisk saltsyre. De utfelte krystaller avsuges og vaskes med eter. Smeltepunkt: 192-193°C. 2 g (5.4 mmol) of g-acetoxy-g-(4-amino-3-chloro-5-trifluoro-methylphenyl)-acetic acid-tert.butylamide are dissolved in 15 ml of absolute tetrahydrofuran and placed in one portion under nitrogen at 27 ml of a 1 molar solution of borane in tetrahydrofuran. After 4 hours of boiling under reflux cooling, a further 15 ml of 1 molar borane solution is added and further heated for 2 hours under reflux cooling. The excess of borane is then destroyed with acetone, the boron complex is cleaved with water, and then the solvent is evaporated in vacuo. The aqueous distillation residue is acidified with 2N hydrochloric acid to pH 1, made alkaline again with ammonia and extracted with ether. The ether extract is extracted with 0.5N hydrochloric acid, the acidic solution is washed with ether, made alkaline with ammonia and extracted again with ether. The ether extract is washed with water, dried with magnesium sulphate and evaporated in vacuo. The oily evaporation residue is dissolved in ether and acidified with ethereal hydrochloric acid. The precipitated crystals are suctioned off and washed with ether. Melting point: 192-193°C.

Eksempel 6 Example 6

g- acetoksy- g-( 4- amino- 3, 5- diklor- fenyl)- N- tert- butyl- acetamid g- acetoxy- g-(4- amino- 3, 5- dichloro- phenyl)- N- tert- butyl- acetamide

Til en oppløsning av 14,1 g (0,08 mol) 4~amino-3,5-diklor-benzaldehyd i 60 ml metylenklorid settes ved romtemperatur og under omrøring 3,6 g (0,06 mol) eddiksyre og 2,5 g (0,03 mol) tert.butyl-isonitril. Derefter oppvarmes reaksjonsblandingen i 3 timer under tilbakeløpskjøling. Efter at den ovenstående operasjon (tilsetning av eddiksyre, tert.butyl-isonitril og oppvarmning under tilbakeløpskjøling) er gjentatt 4 ganger, heller man reaksjonsblandingen i kald 2N natronlut og fra-skiller den organiske fase. Efter vasking med vann og tørring av den organiske fase over natriumsulfat foretas inndampning i vakuum, og residuet krystalliseres fra metylenklorid/heksan. Smeltepunkt: 175-176°C. 3.6 g (0.06 mol) acetic acid and 2.5 g (0.03 mol) tert-butyl isonitrile. The reaction mixture is then heated for 3 hours under reflux. After the above operation (addition of acetic acid, tert-butyl isonitrile and heating under reflux) is repeated 4 times, the reaction mixture is poured into cold 2N caustic soda and the organic phase is separated. After washing with water and drying the organic phase over sodium sulphate, evaporation is carried out in vacuo, and the residue is crystallized from methylene chloride/hexane. Melting point: 175-176°C.

Eksempel 7 Example 7

g- ( 4- amino- 3, 5- diklor- fenyl)- a- benzoyloksy- N- tert. butyl- acetamid Fremstilles fra 4-amino-3,5-diklor-benzaldehyd, tert.butyl-isonitril og benzoesyre" i kloroform og ved tilbakeløpstemperatur analogt med eksempel 4. g-( 4- amino- 3, 5- dichloro- phenyl)- a- benzoyloxy- N- tert. butyl acetamide Prepared from 4-amino-3,5-dichloro-benzaldehyde, tert-butyl isonitrile and benzoic acid" in chloroform and at reflux temperature analogously to example 4.

Smeltepunkt: 189-192°C (sintring fra 185°C). Melting point: 189-192°C (sintering from 185°C).

Eksempel 8 Example 8

g-( 4- amino- 3, 5- diklor- fenyl)- g- valeroyloksy- N- tert. butyl- acetamid g-(4-amino-3,5-dichloro-phenyl)-g-valeroyloxy-N- tert. butyl acetamide

Fremstilles fra 4~amino-3,5-diklor-benzaldehyd, tert.butyl-isonitril og valeriansyre analogt med eksempel 4. Prepared from 4-amino-3,5-dichloro-benzaldehyde, tert-butyl isonitrile and valeric acid analogously to example 4.

Smeltepunkt: 95-98°C. Melting point: 95-98°C.

Eksempel 9 Example 9

1-( 4- amino- 3, 5- diklor- fenyl)- 2- tert. butylamino- etanol 1-(4-amino-3,5-dichloro-phenyl)-2-tert. butylamino-ethanol

Fremstilles fra g<->(4-amino-3,5-diklor-fenyl)-g<->benzoyloksy-N-tert.butyl-acetamid og litiumaluminiumhydrid i tetrahydrofuran analogt med eksempel 3. Smeltepunkt for hydrokloridet: 174-175°C. Prepared from g<->(4-amino-3,5-dichloro-phenyl)-g<->benzoyloxy-N-tert.butyl-acetamide and lithium aluminum hydride in tetrahydrofuran analogously to example 3. Melting point for the hydrochloride: 174-175° C.

Eksempel 10 Example 10

1-( 4- amino- 3, 5- diklor- fenyl)- 2- tert. butylamino- etanol 1-(4-amino-3,5-dichloro-phenyl)-2-tert. butylamino-ethanol

Fremstilles fra 4-amino-3,5-diklor-benzaldehyd, tert.butyl-isonitril og valeriansyre analogt med eksempel 2 og 5 uten isolering av det dannede a-(4-amino-3,5-diklorfenyl)-N-tert.-buty1-a-valeroyloksy-acetamid. Prepared from 4-amino-3,5-dichloro-benzaldehyde, tert.butyl-isonitrile and valeric acid analogously to examples 2 and 5 without isolation of the formed a-(4-amino-3,5-dichlorophenyl)-N-tert. -buty1-α-valeroyloxy-acetamide.

Smeltepunkt for hydrokloridet: 174-175°C. Melting point for the hydrochloride: 174-175°C.

Analogt med de ovenstående eksempler ble følgende forbindelser fremstilt: 1-(4-amino-3-brom-5-fluor-fenyl)-2-tert.butylamino-etanol-hydroklorid, Analogous to the above examples, the following compounds were prepared: 1-(4-amino-3-bromo-5-fluoro-phenyl)-2-tert-butylamino-ethanol hydrochloride,

Smeltepunkt: 207-208°C, Melting point: 207-208°C,

1-(4-amino-3-klor~5-fluor-fenyl)-2-cyklopropylamino-etanol-hydroklorid, 1-(4-amino-3-chloro~5-fluoro-phenyl)-2-cyclopropylamino-ethanol hydrochloride,

Smeltepunkt: 175-177°C, Melting point: 175-177°C,

1-(4-amino-3-klor-5-fluor-fenyl)-2-tert.butylamino-etanol-hydroklorid, 1-(4-amino-3-chloro-5-fluoro-phenyl)-2-tert-butylamino-ethanol hydrochloride,

Smeltepunkt: 206-208°C, Melting point: 206-208°C,

1-(4-amino-3-klor-5-trifluormety1-fenyl)-2-cyklobutylamino-etanol-hydroklorid, 1-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-cyclobutylamino-ethanol hydrochloride,

Smeltepunkt: 177-178°C, Melting point: 177-178°C,

1-(4-amino-3-brom-5-fluor-fenyl)-2-cyklobutylamino-etanol-hydroklorid, 1-(4-amino-3-bromo-5-fluoro-phenyl)-2-cyclobutylamino-ethanol hydrochloride,

Smeltepunkt: 164-166°C, Melting point: 164-166°C,

1-(4-amino-3-klor-5-trifluormetyl-fenyl)-2-tert.pentylamino-etanol-hydroklorid, 1-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert-pentylamino-ethanol hydrochloride,

Smeltepunkt: 176-178°C (spaltn.) Melting point: 176-178°C (dec.)

1-(4-amino-3-klor-5-fluor-fenyl)-2-isopropylamino-etanol-hydroklorid, 1-(4-amino-3-chloro-5-fluoro-phenyl)-2-isopropylamino-ethanol hydrochloride,

Smeltepunkt: 152-154°C (spaltn.) Melting point: 152-154°C (dec.)

1-(4-amino-3-brom-5-tri fluormety1-fenyl)-2-cyklopentylamino-etanol, 1-(4-amino-3-bromo-5-trifluoromethyl-phenyl)-2-cyclopentylamino-ethanol,

Smeltepunkt: 100-102,5°C (spaltn.) Melting point: 100-102.5°C (dec.)

Claims (1)

Fremgangsmåte for fremstilling av nye a-acyloksy-acetamiderProcess for the production of new α-acyloxy-acetamides med den generelle formelwith the general formula hvorwhere betyr et klor- eller bromatom,means a chlorine or bromine atom, R2 betyr en trifluormetylgruppe, et fluor- eller kloratom, R^ betyr en forgrenet alkylrest eller en cykloalkylgruppe med hver 3 til 5 karbonatomer, og R^ betyr gruppen COR hvor R er en alkylrest med 1-4 karbonR2 means a trifluoromethyl group, a fluorine or chlorine atom, R^ means a branched alkyl residue or a cycloalkyl group each having 3 to 5 carbon atoms, and R^ means the group COR where R is an alkyl residue with 1-4 carbons atomer eller en fenylrest,atoms or a phenyl residue, karakterisert ved at et 4-amino-benzaldehyd med den generelle formelcharacterized in that a 4-amino-benzaldehyde of the general formula hvor R^ og R2 er som innledningsvis angitt, omsettes med et isonitril med den generelle formelwhere R 1 and R 2 are as indicated at the outset, is reacted with an isonitrile of the general formula hvor R^ er som innledningsvis angitt, og med en karboksylsyre med den generelle formelwhere R^ is as stated at the outset, and with a carboxylic acid of the general formula hvor R. er som innledningsvis angitt.where R. is as indicated at the outset.
NO794314A 1979-01-10 1979-12-28 PROCEDURE FOR THE PREPARATION OF NEW ALFA-ACYLOXY-ACETAMIDES NO148522C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI790067A FI59396C (en) 1979-01-10 1979-01-10 PROCEDURE FOR THE FRAMSTATION OF AV 2- (4-AMINO-3,5-DICHLOROPHENYL) -2-CARBOXY-N-TERT-BUTYL ACETAMIDER
DE19792942723 DE2942723A1 (en) 1979-10-23 1979-10-23 Prepn. of broncholytic phenyl-ethanolamine derivs. - via new 2-acyloxy-2-phenyl-acetamide derivs.

Publications (3)

Publication Number Publication Date
NO794314L NO794314L (en) 1980-07-11
NO148522B true NO148522B (en) 1983-07-18
NO148522C NO148522C (en) 1983-10-26

Family

ID=25781629

Family Applications (2)

Application Number Title Priority Date Filing Date
NO794314A NO148522C (en) 1979-01-10 1979-12-28 PROCEDURE FOR THE PREPARATION OF NEW ALFA-ACYLOXY-ACETAMIDES
NO823159A NO148997C (en) 1979-01-10 1982-09-17 PROCEDURE FOR THE PREPARATION OF PHENYLETANOLAMINES

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO823159A NO148997C (en) 1979-01-10 1982-09-17 PROCEDURE FOR THE PREPARATION OF PHENYLETANOLAMINES

Country Status (18)

Country Link
AT (1) AT367398B (en)
BG (1) BG33584A3 (en)
CA (1) CA1146958A (en)
CH (1) CH645611A5 (en)
CS (1) CS214689B2 (en)
DD (2) DD150198A5 (en)
DK (2) DK159263C (en)
ES (1) ES487548A0 (en)
GR (1) GR74391B (en)
HU (2) HU188207B (en)
NL (1) NL8000126A (en)
NO (2) NO148522C (en)
PL (2) PL126046B1 (en)
PT (1) PT70661A (en)
RO (1) RO78779A (en)
SE (2) SE447102B (en)
SU (1) SU884563A3 (en)
YU (1) YU4880A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102020008433A2 (en) 2020-04-28 2021-11-03 Universidade Federal Do Parana ARTHROPOD REPELLENTS OBTAINED FROM THE CHEMICAL TRANSFORMATION OF LACTIC ACID, LACTATES OR OTHER LACTIC ACID DERIVATIVES

Also Published As

Publication number Publication date
PL126046B1 (en) 1983-07-30
PL126876B1 (en) 1983-09-30
DK8480A (en) 1980-07-11
SE452979B (en) 1988-01-04
NO148522C (en) 1983-10-26
BG33584A3 (en) 1983-03-15
NO794314L (en) 1980-07-11
DK159262B (en) 1990-09-24
CA1146958A (en) 1983-05-24
YU4880A (en) 1983-06-30
DK159262C (en) 1991-02-18
SE8405631L (en) 1984-11-09
HU188207B (en) 1986-03-28
ES8102547A1 (en) 1981-01-16
DK159263C (en) 1991-02-18
ES487548A0 (en) 1981-01-16
SE8405631D0 (en) 1984-11-09
GR74391B (en) 1984-06-28
ATA3380A (en) 1981-11-15
NO148997B (en) 1983-10-17
DD156179A5 (en) 1982-08-04
DD150198A5 (en) 1981-08-19
CS214689B2 (en) 1982-05-28
SE447102B (en) 1986-10-27
NO148997C (en) 1984-01-25
NL8000126A (en) 1980-07-14
DK159263B (en) 1990-09-24
PT70661A (en) 1980-02-01
HU181681B (en) 1983-11-28
AT367398B (en) 1982-06-25
SU884563A3 (en) 1981-11-23
DK517289A (en) 1989-10-18
CH645611A5 (en) 1984-10-15
PL221288A1 (en) 1980-12-15
NO823159L (en) 1980-07-11
DK517289D0 (en) 1989-10-18
RO78779A (en) 1982-04-12
SE8000175L (en) 1980-07-11

Similar Documents

Publication Publication Date Title
US4920133A (en) Quinoline derivatives and use thereof as antagonists of leukotriene D4
SU659081A3 (en) Method of obtaining phenylethylamines or salts thereof
SK69695A3 (en) Process for preparing benzofuran compounds
US4172093A (en) Pharmacodynamically active indan derivatives
FI86545B (en) FORMULATION OF A THERAPEUTIC VERIFICATION OF 1-AROYL-4-ARALKYLPIPERAZINER.
CA1240325A (en) 4-amino-2-piperidinoquinazolines
US4012407A (en) 2-Cyano indan-1,3-diones
Dickerman et al. Studies In Piperidone Chemistry. I. A Synthesis Of 5-Homopiperazinones
JPH02225468A (en) Method for reducing piperidine-dione derivative and intermediate therefrom
US4803270A (en) Process of producing fluoroaniline derivatives
AU594858B2 (en) Process and intermediates for quinolonecarboxylic acid
NO148522B (en) PROCEDURE FOR THE PREPARATION OF NEW ALFA-ACYLOXY-ACETAMIDES
JPS5826342B2 (en) Shinkipyrazolyl oxysaccharide composition
JP3901239B2 (en) Arylalkane derivatives
JPS6230989B2 (en)
US4634769A (en) Process for the preparation of 8-halo-5,6-dialkoxyquinazoline-2,4-diones and their salts
US5650514A (en) 3-substituted quinoline-5-carboxylic acid derivatives and processes for their preparation
Balenovic et al. A Synthesis of Nγ-Phthaloyl Derivatives of Basic Amino Acids. Amino Acids. VII
CZ614690A3 (en) 3-methoxy-4-£1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl) indol-3-ylmethyl|-n-(2-methylphenylsulfonyl)benzamide, pharmaceutically acceptable salt thereof, process of their preparation and pharmaceutical compositions containing thereof
NO147749B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW THERAPEUTICALLY ACTIVE N-ACRYL-2-HYDROXY-1,3-DIAMINOPROPANES
US5175297A (en) Methyl-quinoline derivatives as mefloquin intermediates and process for preparation thereof
US5578728A (en) Process for the preparation of a benzo(a)quinolizione derivative
JPS6317828B2 (en)
US5104990A (en) Process for the preparation of 3-aryl-3-aminoalkyl-2,6-dioxohexahydropyridines
NO144099B (en) MACHINE FOR MACHINE FLAMMING OF SOME DEFECTS ON THE SURFACE OF A METAL BODY